← back to search

Mats Eriksson

Karolinska University Hospital · SE
Area of research
Surgery · Cancer Research
Research interest
Research interests include Lipoproteins and Cardiovascular Health, Cholesterol and Lipid Metabolism, Cancer, Lipids, and Metabolism, and Diabetes, Cardiovascular Risks, and Lipoproteins.
h-index
44
citations
10,714
works
188
NIH funding
primary concept
Medicine
email

Recent publications

The combination of statin and ezetimibe is safe, effective, and preferable.
2025cited by 0position: contributordoi
Prevalence of atherosclerosis in individuals with prediabetes and diabetes compared to normoglycaemic individuals—a Swedish population-based study
Cardiovascular Diabetology 2023cited by 27position: middledoi
Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population
Circulation 2021cited by 405position: middledoi
Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population.
2021cited by 303position: contributordoi
Treatment with the natural <scp>FXR</scp> agonist chenodeoxycholic acid reduces clearance of plasma <scp>LDL</scp> whilst decreasing circulating <scp>PCSK</scp>9, lipoprotein(a) and apolipoprotein C‐<scp>III</scp>
Journal of Internal Medicine 2017cited by 62position: middledoi
Diabetes Mellitus Is Associated With Reduced High-Density Lipoprotein Sphingosine-1-Phosphate Content and Impaired High-Density Lipoprotein Cardiac Cell Protection
Arteriosclerosis Thrombosis and Vascular Biology 2016cited by 71position: middledoi
LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial
Cardiovascular Diabetology 2016cited by 57position: lastdoi
The Swedish CArdioPulmonary BioImage Study: objectives and design
Journal of Internal Medicine 2015cited by 451position: middledoi
Culturing of HepG2 cells with human serum improve their functionality and suitability in studies of lipid metabolism
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2015cited by 22position: middledoi
Reductions in serum levels of <scp>LDL</scp> cholesterol, apolipoprotein B, triglycerides and lipoprotein(a) in hypercholesterolaemic patients treated with the liver‐selective thyroid hormone receptor agonist eprotirome
Journal of Internal Medicine 2014cited by 56position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Camilla Pramfalk · University of Lausanne2 papers (2015–2016)Bo Angelin · Karolinska University Hospital2 papers (2014–2017)Miranda Van Eck · Leiden University1 papers (2016–2016) · 1 papers (2014–2014) · 1 papers (2017–2017)Paolo Parini · Karolinska Institutet1 papers (2015–2015)François R. Jornayvaz · University of Geneva1 papers (2016–2016)Brenda R. Kwak · University of Geneva1 papers (2016–2016)Mats Rudling · Uppsala University1 papers (2017–2017)Patrik Löfgren · Karolinska University Hospital1 papers (2016–2016)Richard W. James · University of Lausanne1 papers (2016–2016)Miguel A. Frias · University of Lausanne1 papers (2016–2016)Itamar Raz · Thrombolysis in Myocardial Infarction Study Group1 papers (2016–2016)Jonas Brinck · Karolinska University Hospital1 papers (2016–2016)Lawrence A. Leiter · St. Michael's Hospital1 papers (2016–2016)Stephen C. Bain · Swansea Bay University Health Board1 papers (2016–2016) · 1 papers (2016–2016) · 1 papers (2016–2016)E. Chester Ridgway · University of Colorado Denver1 papers (2014–2014)L. Van Gaal · University of Antwerp1 papers (2016–2016)